L'hospitalet De Llobregat, BARCELONA1 Active Studies

Ovarian Cancer Clinical Trials in L'hospitalet De Llobregat, BARCELONA

Find 1 actively recruiting ovarian cancer clinical trials in L'hospitalet De Llobregat, BARCELONA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
78
Enrolling

Recruiting Ovarian Cancer Studies in L'hospitalet De Llobregat

About Ovarian Cancer Clinical Trials in L'hospitalet De Llobregat

Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.

There are currently 1 ovarian cancer clinical trials recruiting participants in L'hospitalet De Llobregat, BARCELONA. These studies are seeking a combined 78 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ovarian Cancer Clinical Trials in L'hospitalet De Llobregat — FAQ

Are there ovarian cancer clinical trials in L'hospitalet De Llobregat?

Yes, there are 1 ovarian cancer clinical trials currently recruiting in L'hospitalet De Llobregat, BARCELONA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in L'hospitalet De Llobregat?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the L'hospitalet De Llobregat research site will contact you about next steps.

Are clinical trials in L'hospitalet De Llobregat free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many L'hospitalet De Llobregat studies also compensate for your time and travel.

What ovarian cancer treatments are being tested?

The 1 active trials in L'hospitalet De Llobregat are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.

Data updated March 2, 2026 from ClinicalTrials.gov